Article Details

Not All COVID Patients Benefit From JAK Inhibitor | MedPage Today

Retrieved on: 2024-05-28 17:01:43

Tags for this article:

Click the tags to see associated articles and topics

Not All COVID Patients Benefit From JAK Inhibitor | MedPage Today. View article details on hiswai:

Excerpt

People randomized to the Janus kinase (JAK) inhibitor baricitinib (Olumiant) to treat COVID-19 pneumonia in a clinical trial only saw a survival ...

Article found on: www.medpagetoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up